Analyses public health flexibilities in the TRIPS Agreement and provides examples where and how have they been used by governments. It can be used by legislators and policy makers in discussions on adopting or reforming legislation, in formulating national intellectual property rights (IPR) and public health policies, and in negotiating WTO accession agreements, or bilateral trade agreements.